info@seagull-health.com
SeagullHealth
search
Alpelisib(PIQRAY)
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
Alpelisib(PIQRAY) Instructions:Uses,Dosage, Side Effects
PIQRAY, with the generic name alpelisib, is a kinase inhibitor that specifically targets the phosphatidylinositol-3-kinase alpha (PI3Kα) protein. Its active pharmaceutical ingredient is alpelisib, formulated as film-coated tablets for oral administration. It is designed for use in combination with fulvestrant to target cancers harboring specific genetic mutations.
PIQRAY, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer, as detected by an FDA-approved test, following disease progression on or after endocrine-based regimen.
300 mg (two 150 mg tablets) taken orally once daily with food.
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
- mailbox：info@lucius.la
